MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/sxmrev/qead006

Медицинская библиотека · Sexual medicine reviews · 2023

Sexual dysfunctions in breast cancer patients: evidence in context.

Vizza Riccardo, Capomolla Elisabetta Maria, Tosetto Livia, Corrado Giacomo, Bruno Valentina, Chiofalo Benito, Di Lisa Francesca Sofia, Filomeno Lorena, Pizzuti Laura, Krasniqi Eriseld, Sanguineti Giuseppe, Villa Alice, Giannini Andrea, Kayal Ramy, Stranges Vincenzo, Tomao Silverio, Botti Claudio, Tomao Federica, Barba Maddalena, Vizza Enrico, Ciliberto Gennaro, Vici Patrizia

СтатьяПоддержка исследования: вне правительства СШАОбзорПеревод пока не подготовлен

Аннотация

INTRODUCTION

In breast cancer patients, endocrine therapy may exert a negative impact on sexual functioning in both genders, with potentially relevant consequences concerning quality of life and treatment adherence. The availability of effective interventions to maintain and/or restore sexual health in breast cancer patients is a key issue to a research agenda.

OBJECTIVES

To summarize and critically discuss the most updated and qualitatively relevant literature on the therapeutic approach to sexual impairment in breast cancer patients, with a focus on patients treated with endocrine therapy.

METHODS

We searched PubMed from its inception to February 2022 for observational and intervention trials including participants with sexual dysfunctions. We were particularly interested in studies of breast cancer patients with sexual dysfunctions while undergoing endocrine therapy. We developed a search strategy with the aim of maximizing the number of articles considered for screening and potential inclusion.

RESULTS

Forty-five studies were selected: 3 observational and 42 intervention studies. Thirty-five studies were exclusively focused on female breast cancer populations. We could not identify studies exclusively focused on or also including male breast cancer patients. Overall, in female patients, the available armamentarium encompasses vaginal lubricants, moisturizers, estrogens, dehydroepiandrosterone, CO2 laser, ospemifene, and counseling. None of these interventions has been demonstrated to completely solve sexual dysfunctions when singularly considered. More favorable outcomes have come from the combination of different therapies.

CONCLUSION

In female breast cancer, future research is oriented toward the gain of evidence on combined therapies and long-term data on safety issues on the most promising interventions. The lack of evidence on sexual disturbances in male breast cancer patients remains a major concern.

Для цитирования: Vizza Riccardo, Capomolla Elisabetta Maria, Tosetto Livia, Corrado Giacomo, Bruno Valentina, Chiofalo Benito, Di Lisa Francesca Sofia, Filomeno Lorena, Pizzuti Laura, Krasniqi Eriseld, Sanguineti Giuseppe, Villa Alice, Giannini Andrea, Kayal Ramy, Stranges Vincenzo, Tomao Silverio, Botti Claudio, Tomao Federica, Barba Maddalena, Vizza Enrico, Ciliberto Gennaro, Vici Patrizia. Sexual dysfunctions in breast cancer patients: evidence in context.. Sexual medicine reviews. 2023. DOI: 10.1093/sxmrev/qead006.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.